What is DOW Testing?
The Diabetes, Obesity, and Weight (DOW) Panel is a cutting-edge genetic testing solution that uses Next-Generation Sequencing (NGS) technology to assess your inherited risk for diabetes, obesity, and related metabolic conditions. These health issues affect millions worldwide and carry serious long-term risks. Unlike traditional tests that only look at a handful of genetic factors, our comprehensive NGS approach analyzes a broad range of genes to deliver a deeper, more accurate understanding of your risk—giving you and your healthcare provider a powerful tool for early detection, prevention, and personalized care.
How Will I Benefit?
The DOW Panel provides a complete, individualized assessment of your genetic predisposition to diabetes and obesity. By identifying key genetic variants early, you gain valuable insights that empower you to make informed lifestyle changes and take proactive steps to manage your health. Early risk detection means you can work with your care team to develop a targeted prevention or management plan—potentially helping you delay or even avoid the onset of these serious conditions altogether.
What We Offer
Our DOW Panel analyzes a carefully selected group of genes that research has strongly linked to diabetes and obesity risk. Using advanced NGS technology, we assess multiple genetic variations at once to create a comprehensive risk profile tailored to you. Your results come in a clear, detailed report that highlights your individual risk factors, offers genetic insights, and provides actionable recommendations.
With this knowledge, you and your healthcare team can design a customized plan focused on prevention, healthy weight management, and long-term wellness. Take charge of your future health with the power of genetic insight—because the best time to protect your well-being is before problems begin.
